PAM
VRTX icon

Parvin Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Parvin Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18
Closed -$8.73K – 365
2025
Q1 		$8.73K Buy
+18
New +$8.73K 0.01% 263